SecSonar.com

Whitehawk Therapeutics Inc (WHWK)

Whitehawk Therapeutics Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Whitehawk Therapeutics Inc (WHWK) is a Biotechnology company based in US with a market capitalization of $232.4M. Revenue declined 72.5% year-over-year and free cash flow was negative at -$98M. This page tracks WHWK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 40 employees · IPO Aug 1, 2017

Valuation

Valuation & price

$4.70 · as of May 17, 2026 · -7.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.71

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.78$3.20$1.62Jul 25Dec 25Jun 26Jul 7, 25$1.98Jul 9, 25$2.01Jul 11, 25$1.91Jul 15, 25$1.94Jul 17, 25$1.85Jul 21, 25$1.85Jul 23, 25$2.01Jul 25, 25$1.95Jul 29, 25$1.77Jul 31, 25$1.75Aug 4, 25$1.76Aug 6, 25$1.80Aug 8, 25$1.75Aug 12, 25$1.71Aug 14, 25$1.62Aug 19, 25$1.65Aug 21, 25$1.65Aug 25, 25$1.70Aug 27, 25$1.81Aug 29, 25$1.81Sep 3, 25$1.81Sep 5, 25$1.82Sep 9, 25$1.80Sep 11, 25$2.01Sep 15, 25$1.86Sep 17, 25$1.95Sep 19, 25$1.92Sep 23, 25$1.92Sep 25, 25$1.89Sep 29, 25$1.92Oct 2, 25$1.94Oct 6, 25$2.15Oct 8, 25$2.13Oct 10, 25$2.02Oct 14, 25$1.97Oct 16, 25$2.61Oct 20, 25$2.66Oct 22, 25$2.37Oct 24, 25$2.41Oct 28, 25$2.40Oct 30, 25$2.25Nov 3, 25$2.22Nov 5, 25$2.25Nov 7, 25$2.07Nov 11, 25$2.23Nov 14, 25$2.14Nov 18, 25$2.14Nov 20, 25$1.99Nov 24, 25$2.21Nov 26, 25$2.30Dec 1, 25$2.26Dec 3, 25$2.24Dec 5, 25$2.49Dec 9, 25$2.57Dec 11, 25$2.50Dec 15, 25$2.36Dec 17, 25$2.30Dec 19, 25$2.56Dec 23, 25$2.65Dec 26, 25$2.67Dec 31, 25$2.42Jan 5, 26$2.53Jan 7, 26$2.67Jan 9, 26$2.64Jan 13, 26$2.75Jan 15, 26$2.79Jan 20, 26$2.86Jan 22, 26$2.85Jan 26, 26$2.68Jan 28, 26$2.70Jan 30, 26$2.70Feb 3, 26$2.88Feb 5, 26$2.71Feb 9, 26$2.78Feb 11, 26$2.83Feb 17, 26$2.94Feb 19, 26$3.05Feb 23, 26$3.00Feb 25, 26$3.30Feb 27, 26$3.51Mar 3, 26$3.30Mar 5, 26$3.57Mar 9, 26$4.08Mar 11, 26$4.01Mar 13, 26$3.91Mar 17, 26$3.95Mar 19, 26$3.59Mar 23, 26$3.65Mar 25, 26$3.59Mar 27, 26$3.16Apr 1, 26$3.54Apr 6, 26$3.50Apr 8, 26$3.41Apr 10, 26$3.39Apr 14, 26$4.00Apr 16, 26$4.23Apr 20, 26$4.23Apr 22, 26$4.23Apr 24, 26$4.03Apr 28, 26$4.13Apr 30, 26$4.01May 4, 26$4.16May 6, 26$4.15May 8, 26$3.97May 12, 26$3.92May 15, 26$4.70May 19, 26$4.07May 21, 26$4.30May 26, 26$4.77May 28, 26$4.78Jun 1, 26$4.49Jun 3, 26$4.34Jun 5, 26$4.15Jun 9, 26$4.22Jun 11, 26$4.06Jun 15, 26$4.10Jun 17, 26$4.22Jun 22, 26$4.46Jun 24, 26$4.39Jun 30, 26$4.67
$1.6052-week range$5.10
Loading valuation history…

Fundamentals

Key fundamentals

$232.4M

Market cap

-72.5%

Revenue growth (YoY)

89.4%

Gross margin

-$98M

Free cash flow (USD)

-$145.7M

Net debt

Net cash position

129.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$749.0KFY 2020$14.6MFY 2021$1.1MFY 2022$15.2MFY 2023$24.4MFY 2024$26.0MFY 2025$7.1M
$749K$7.1M

Free cash flow by year

2019 → 2025

FY 2019$-7.6MFY 2020$-12.7MFY 2021$-22.5MFY 2022$-50.1MFY 2023$-63.6MFY 2024$-61.2MFY 2025$-98.0M
-$7.6M-$98M

Gross margin by year

2021 → 2025

FY 2021-1656.3%FY 2022-123.4%FY 2023-112.4%FY 2024-108.0%FY 202589.4%
-1656.3%89.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

5

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • FinancingSecurities RegistrationMay 29, 2026Filing
  • 8-K eventADC Pipeline ExpansionMay 21, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • Insider sellInsider Sell $882KGiacobello Scott M. · CHIEF FINANCIAL OFFICER · $882KApr 17, 2026Filing
  • Insider sellInsider Sell $428KBALL BRYAN · See remarks · $427.9KApr 15, 2026Filing
  • Insider sellInsider Sell $201KBALL BRYAN · See remarks · $201.1KApr 13, 2026Filing
  • Insider sellInsider Sell $49KLennon David James · Director, CHIEF EXECUTIVE OFFICER · $49KApr 10, 2026Filing

Questions

Frequently asked questions

What is Whitehawk Therapeutics Inc's market cap?

Whitehawk Therapeutics Inc (WHWK) has a market capitalization of $232.4M.

What is WHWK's P/E ratio?

A meaningful P/E ratio is not available for WHWK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is WHWK's price-to-book (P/B) ratio?

WHWK trades at 1.71 times book value per share.

Are insiders buying WHWK stock?

SEC Form 4 filings show no open-market insider buys at Whitehawk Therapeutics Inc in the last 90 days (5 sells).

Same arena

Related companies in Biotechnology

SGMT

Sagimet Biosciences Inc.

$235M

VYGR

Voyager Therapeutics, Inc.

$235.3M

QSI

Quantum-Si incorporated

$235.4M

CRBU

Caribou Biosciences, Inc.

$235.6M

OBIO

Orchestra BioMed Holdings, Inc.

$236.8M

ARCT

Arcturus Therapeutics Holdings Inc.

$225.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.